The HHS Guidelines for Regulatory Impact Analysis (2016) discuss an approach to valuing mortality risk reductions, commonly referred to as the value per statistical life (VSL). This appendix provides background information on the VSL estimates, describes the process for updating these values, reports the estimates in 2020 dollars, and illustrates their application. It is intended to aid analysts and stakeholders in understanding the calculations and the results. Analysts may also wish to incorporate extracts from this appendix into the documentation for individual regulatory analyses. ASPE has also created an Excel workbook that can be used to explore the calculations in more detail and to update these values.
- Guidelines for Regulatory Impact Analysis
- Guidelines for Regulatory Impact Analysis: A Primer
- Valuing Time in U.S. Department of Health and Human Services Regulatory Impact Analyses: Conceptual Framework and Best Practices
- Estimating Medical Costs for Regulatory Benefit-Cost Analysis: Conceptual Framework and Best Practices
*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Aaron Kearsley, (202) 507-0925, firstname.lastname@example.org. Content will be updated pending the outcome of the Section 508 review.